|
|
|
|
Prestige Consumer Healthcare Inc (PBH) |
|
|
|
| |
PBH's Net Income Growth by Quarter and Year
Prestige Consumer Healthcare Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| PBH Net Income (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| IV Quarter |
March |
-
|
116.78
|
-446.16
|
-149.41
|
| III Quarter |
December |
-
|
122.62
|
120.07
|
115.71
|
| II Quarter |
September |
-
|
123.97
|
117.62
|
104.96
|
| I Quarter |
June |
107.48
|
121.99
|
126.17
|
134.13
|
| FY |
|
107.48
|
485.36
|
-82.30
|
205.39
|
| PBH Net Income first quarter 2025 Y/Y Growth Comment |
Prestige Consumer Healthcare Inc reported fall in Net Income in the first quarter 2025 by -11.89% to $ 107.48 millions, from the same quarter in 2024.
The decline in the first quarter 2025 Prestige Consumer Healthcare Inc 's Net Income compares unfavorably to the Company's average Net Income increase of 16.88%.
Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Net Income growth. While Prestige Consumer Healthcare Inc ' s Net Income decrease of -11.89% ranks overall at the positon no. 585 in the first quarter 2025.
|
| PBH Net Income ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| IV Quarter |
March |
- |
- |
- |
- |
| III Quarter |
December |
- |
2.12 % |
3.77 % |
22.38 % |
| II Quarter |
September |
- |
5.4 % |
12.06 % |
8.78 % |
| I Quarter |
June |
-11.89 % |
-3.31 % |
-5.93 % |
31.67 % |
| FY |
|
- |
- |
- |
24.72 % |
PBH Net Income (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| IV Quarter |
March |
- |
-4.76 % |
- |
- |
| III Quarter |
December |
- |
-1.09 % |
2.08 % |
10.24 % |
| II Quarter |
September |
- |
1.62 % |
-6.78 % |
-21.75 % |
| I Quarter |
June |
-7.96 % |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
24.72 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 588.4 % |
16.88 % |
-143.81 % |
| (Dec 31 2017) |
|
(Jun 30 2023) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 588.4 % |
16.88 % |
-143.81 % |
| (Dec 31 2017) |
|
(Jun 30 2023) |
|
| Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Prestige Consumer Healthcare Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 411.21 % |
31.76 % |
-90.45 % |
| (Mar 31 2014) |
|
|
| PBH's I. Quarter Q/Q Net Income Comment |
In the I. Quarter 2025 Prestige Consumer Healthcare Inc disclosed drop in Net Income sequentially by -7.96% to $ 107.48 millions, from $ 116.78 millions achived in the previous reporting period.
Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare Inc 's Net Income growth quarter on quarter, overall rank is 767. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 411.21 % |
31.76 % |
-90.45 % |
| (Mar 31 2014) |
|
|
| PBH's I. Quarter Q/Q Net Income Comment |
In the I. Quarter 2025 Prestige Consumer Healthcare Inc disclosed drop in Net Income sequentially by -7.96% to $ 107.48 millions, from $ 116.78 millions declared in the previous reporting period.
Within Major Pharmaceutical Preparations industry 11 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare Inc 's Net Income growth quarter on quarter, overall rank is 767. |
|
Prestige Consumer Healthcare Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Net Income 12 Months Ending |
$ 470.86 |
$ 485.36 |
$ -77.58 |
$ -80.13 |
$ -86.49 |
| Y / Y Net Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Net Income Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Net Income Change (TTM) |
-2.99 % |
- |
- |
- |
- |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 585 |
# 0 |
# 870 |
# 438 |
# 573 |
| Cumulative Net Income growth
Comment |
In the Jun 30 2024 period, Prestige Consumer Healthcare Inc had cumulative twelve months Net Income of $ 471 millions compare to net loss of $ -86 millions a year ago.
Prestige Consumer Healthcare Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
588.4 % |
16.88 % |
-143.81 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 11 |
| Sector |
# 44 |
| S&P 500 |
# 585 |
|
| Cumulative Net Income growth
Comment |
In the Jun 30 2024 period, Prestige Consumer Healthcare Inc had cumulative twelve months Net Income of $ 471 millions compare to net loss of $ -86 millions a year ago.
Prestige Consumer Healthcare Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
588.4 % |
16.88 % |
-143.81 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 11 |
| Sector |
# 44 |
| S&P 500 |
# 585 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
